Koninklijke Philips N.V.
$28.41
▼
-0.25%
2026-04-22 10:12:13
www.philips.com
NYQ: PHG
Explore Koninklijke Philips N.V. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$27.66 B
Current Price
$28.41
52W High / Low
$27.7 / $19.09
Stock P/E
25.52
Book Value
$13.43
Dividend Yield
0%
ROCE
7.46%
ROE
7.82%
Face Value
—
EPS
$1.11
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Devices
Employees
61,085
Beta
0.96
Debt / Equity
73.57
Current Ratio
1.32
Quick Ratio
0.94
Forward P/E
13.82
Price / Sales
1.52
Enterprise Value
$32.25 B
EV / EBITDA
16
EV / Revenue
1.81
Rating
Hold
Target Price
$33.74
EPS Forecast (FY)
—
Pros
- Short-term liquidity looks comfortable.
- Meaningful dividend yield is available.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Globus Medical, Inc. | $96.1 | 24.49 | $13.01 B | — | 11.18% | 12.29% | $101.4 / $51.79 | $33.86 |
| 2. | DexCom, Inc. | $63.4 | 30.77 | $24.57 B | — | 21.72% | 34.5% | $89.98 / $54.11 | $7.14 |
| 3. | 20/20 Biolabs, Inc. | $1.71 | — | — | — | -253.94% | -5.03% | $50 / $1.51 | $0.01 |
| 4. | Orthofix Medical Inc. | $12.65 | — | $507.83 M | — | -12.14% | -19.34% | $16.99 / $10.24 | $11.3 |
| 5. | Profound Medical Corp. | $7.15 | — | $331 M | — | -57.78% | -67.11% | $12.4 / $5.23 | $1.83 |
| 6. | PAVmed Inc. | $9.44 | 150.27 | $60.26 M | — | -89.22% | -32.34% | $28.44 / $6 | $10.01 |
| 7. | Glaukos Corporation | $123.8 | — | $7.27 B | — | -25.2% | -26.38% | $130.23 / $73.16 | $11.41 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | |
|---|---|---|---|---|---|
| Sales | 5.1 B | 4.3 B | 4.34 B | 4.1 B | 5.04 B |
| Operating Profit | 565 M | 330 M | 401 M | 155 M | 183 M |
| Net Profit | 395 M | 184 M | 240 M | 76 M | -335 M |
| EPS in Rs | 0.42 | 0.19 | 0.25 | 0.08 | -0.35 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 17.83 B | 18.02 B | 18.17 B | 17.83 B |
| Operating Profit | 1.45 B | 513 M | -168 M | -177 M |
| Net Profit | 895 M | -702 M | -466 M | -1.61 B |
| EPS in Rs | 0.94 | -0.74 | -0.49 | -1.69 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 26.94 B | 28.98 B | 29.41 B | 30.69 B |
| Total Liabilities | 15.96 B | 16.93 B | 17.34 B | 17.41 B |
| Equity | 10.96 B | 12.01 B | 12.03 B | 13.25 B |
| Current Assets | 9.93 B | 10.02 B | 9.94 B | 10.26 B |
| Current Liabilities | 7.51 B | 8.14 B | 8.29 B | 7.93 B |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 1.17 B | 1.57 B | 2.14 B | -173 M |
| Investing CF | -737 M | -573 M | -636 M | -1.49 B |
| Financing CF | 107 M | -496 M | -848 M | 500 M |
| Free CF | 504 M | 893 M | 1.49 B | -979 M |
| Capex | -668 M | -676 M | -644 M | -806 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue Growth % | -1.04% | -0.81% | 1.92% | — |
| Earnings Growth % | 227.49% | -50.64% | 71.02% | — |
| Profit Margin % | 5.02% | -3.9% | -2.56% | -9.02% |
| Operating Margin % | 8.12% | 2.85% | -0.92% | -0.99% |
| Gross Margin % | 45.18% | 43.13% | 40.99% | 40.35% |
| EBITDA Margin % | 14.58% | 10.26% | 5.73% | 0.65% |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
| Ex Date | Dividend |
|---|---|
| 2025-05-13 | $0.967 |
| 2022-05-12 | $0.964 |
| 2021-05-10 | $1.033 |
Stock Splits
No stock split history available.